Molecular epidemiology of carbapenem-resistant Pseudomonas aeruginosa carrying metallo-β-lactamase genes in Taiwan

Diagnostic Microbiology and Infectious Disease

Volumn 59, Issue 2, 2007, Pages 211-216

  Huang, Yu Tsung ^a   Chang, Shan Chwen ^a   Lauderdale, Tsai Ling ^b   Yang, Almira J ^a   Wang, Jann Tay ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

Carbapenem resistance; Colistin; Metallo lactamase; Pseudomonas aeruginosa

Indexed keywords

AMIKACIN; AZTREONAM; CARBAPENEM; CEFEPIME; CEFTAZIDIME; CIPROFLOXACIN; COLISTIN; GENTAMICIN; IMIPENEM; INTEGRASE; METALLO BETA LACTAMASE; PIPERACILLIN PLUS TAZOBACTAM; TIMENTIN; TOBRAMYCIN;

AMPLICON; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATE; DNA SEQUENCE; INTEGRON; MOLECULAR EPIDEMIOLOGY; MOLECULAR TYPING; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; PULSED FIELD GEL ELECTROPHORESIS;

ANTI-BACTERIAL AGENTS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CARBAPENEMS; COLISTIN; ELECTROPHORESIS, GEL, PULSED-FIELD; EPIDEMIOLOGY, MOLECULAR; HUMANS; INTEGRASES; INTEGRONS; MICROBIAL SENSITIVITY TESTS; POPULATION SURVEILLANCE; PREVALENCE; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; TAIWAN;

EID: 34848857019     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2007.01.009     Document Type: Article

References (28)

1. Bellais S., Mimoz O., Leotard S., Jacolot A., Petitjean O., and Nordmann P. Efficacy of beta-lactams for treating experimentally induced pneumonia due to a carbapenem-hydrolyzing metallo-beta-lactamase-producing strain of Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 46 (2002) 2032-2034
2. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing, 15th Informational Supplement, M100-S15 (2005), CLSI, Wayne (PA)
3. Falagas M.E., Bliziotis I.A., Kasiakou S.K., Samonis G., Athanassopoulou P., and Michalopoulos A. Outcome of infections due to pandrug-resistant (PDR) Gram-negative bacteria. BMC Infect. Dis. 5 (2005) 24
4. Gales A.C., Tognim M.C., Reis A.O., Jones R.N., and Sader H.S. Emergence of an IMP-like metallo-enzyme in an Acinetobacter baumannii clinical strain from a Brazilian teaching hospital. Diagn. Microbiol. Infect. Dis. 45 (2003) 77-79
5. Gaynes R., and Edwards J.R. Overview of nosocomial infections caused by gram-negative bacilli. Clin. Infect. Dis. 41 (2005) 848-854
6. Hirakata Y., Yamaguchi T., Nakano M., Izumikawa K., Mine M., Aoki S., Kondoh A., Matsuda J., Hirayama M., Yanagihara K., Miyazaki Y., Tomono K., Yamada Y., Kamihira S., and Kohno S. Clinical and bacteriological characteristics of IMP-type metallo-beta-lactamase-producing Pseudomonas aeruginosa. Clin. Infect. Dis. 37 (2003) 26-32
7. Hsueh P.R., Liu C.Y., and Luh K.T. Current status of antimicrobial resistance in Taiwan. Emerg. Infect. Dis. 8 (2002) 132-137
8. Hsueh P.R., Tseng S.P., Teng L.J., and Ho S.W. Pan-drug-resistant Pseudomonas aeruginosa causing nosocomial infection at a university hospital in Taiwan. Clin. Microbiol. Infect. 11 (2005) 670-673
9. Kimura S., Alba J., Shiroto K., Sano R., Niki Y., Maesaki S., Akizawa K., Kaku M., Watanuki Y., Ishii Y., and Yamaguchi K. Clonal diversity of metallo-beta-lactamase-possessing Pseudomonas aeruginosa in geographically diverse regions of Japan. J. Clin. Microbiol. 43 (2005) 458-461
10. Lauderdale T.L., Clifford McDonald L., Shiau Y.R., Chen P.C., Wang H.Y., Lai J.F., and Ho M. The status of antimicrobial resistance in Taiwan among gram-negative pathogens: the Taiwan Surveillance of Antimicrobial Resistance (TSAR) program, 2000. Diagn. Microbiol. Infect. Dis. 48 (2004) 211-219
11. Laupland K.B., Parkins M.D., Church D.L., Gregson D.B., Louie T.J., Conly J.M., Elsayed S., and Pitout J.D. Population-based epidemiological study of infections caused by carbapenem-resistant Pseudomonas aeruginosa in the Calgary Health Region: importance of metallo-beta-lactamase (MBL)-producing strains. J. Infect. Dis. 192 (2005) 1606-1612
12. Lauretti L., Riccio M.L., Mazzariol A., Cornaglia G., Amicosante G., Fontana R., and Rossolini G.M. Cloning and characterization of blaVIM, a new integron-borne metallo-beta-lactamase gene from a Pseudomonas aeruginosa clinical isolate. Antimicrob. Agents Chemother. 43 (1999) 1584-1590
13. Lee K., Lee W.G., Uh Y., Ha G.Y., Cho J., and Chong Y. VIM- and IMP-type metallo-beta-lactamase-producing Pseudomonas spp. and Acinetobacter spp. in Korean hospitals. Emerg. Infect. Dis. 9 (2003) 868-871
14. Lee N.Y., Yan J.J., Lee H.C., Liu K.H., Huang S.T., and Ko W.C. Clinical experiences of bacteremia caused by metallo-beta-lactamase-producing gram-negative organisms. J. Microbiol. Immunol. Infect. 37 (2004) 343-349
15. Lee K., Yum J.H., Yong D., Lee H.M., Kim H.D., Docquier J.D., Rossolini G.M., and Chong Y. Novel acquired metallo-beta-lactamase gene, bla(SIM-1), in a class 1 integron from Acinetobacter baumannii clinical isolates from Korea. Antimicrob. Agents Chemother. 49 (2005) 4485-4491
16. Levin A.S., Barone A.A., Penco J., Santos M.V., Marinho I.S., Arruda E.A., Manrique E.I., and Costa S.F. Intravenous colistin as therapy for nosocomial infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii. Clin. Infect. Dis. 28 (1999) 1008-1011
17. Linden P.K., Kusne S., Coley K., Fontes P., Kramer D.J., and Paterson D. Use of parenteral colistin for the treatment of serious infection due to antimicrobial-resistant Pseudomonas aeruginosa. Clin. Infect. Dis. 37 (2003) e154-e160
18. Marra A.R., Pereira C.A., Gales A.C., Menezes L.C., Cal R.G., de Souza J.M., Edmond M.B., Faro C., and Wey S.B. Bloodstream infections with metallo-beta-lactamase-producing Pseudomonas aeruginosa: epidemiology, microbiology, and clinical outcomes. Antimicrob. Agents Chemother. 50 (2006) 388-390
19. Poh C.L., Yeo C.C., and Tay L. Genome fingerprinting by pulsed-field gel electrophoresis and ribotyping to differentiate Pseudomonas aeruginosa serotype O11 strains. Eur. J. Clin. Microbiol. Infect. Dis. 11 (1992) 817-822
20. Poirel L., Naas T., Nicolas D., Collet L., Bellais S., Cavallo J.D., and Nordmann P. Characterization of VIM-2, a carbapenem-hydrolyzing metallo-beta-lactamase and its plasmid- and integron-borne gene from a Pseudomonas aeruginosa clinical isolate in France. Antimicrob. Agents Chemother. 44 (2000) 891-897
21. Rasmussen B.A., and Bush K. Carbapenem-hydrolyzing beta-lactamases. Antimicrob. Agents Chemother. 41 (1997) 223-232
22. Shibata N., Doi Y., Yamane K., Yagi T., Kurokawa H., Shibayama K., Kato H., Kai K., and Arakawa Y. PCR typing of genetic determinants for metallo-beta-lactamases and integrases carried by gram-negative bacteria isolated in Japan, with focus on the class 3 integron. J. Clin. Microbiol. 41 (2003) 5407-5413
23. Tenover F.C., Arbeit R.D., Goering R.V., Mickelsen P.A., Murray B.E., Persing D.H., and Swaminathan B. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33 (1995) 2233-2239
24. Tsakris A., Pournaras S., Woodford N., Palepou M.F., Babini G.S., Douboyas J., and Livermore D.M. Outbreak of infections caused by Pseudomonas aeruginosa producing VIM-1 carbapenemase in Greece. J. Clin. Microbiol. 38 (2000) 1290-1292
25. Walsh T.R., Toleman M.A., Poirel L., and Nordmann P. Metallo-beta-lactamases: the quiet before the storm?. Clin. Microbiol. Rev. 18 (2005) 306-325
26. Watanabe M., Iyobe S., Inoue M., and Mitsuhashi S. Transferable imipenem resistance in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 35 (1991) 147-151
27. Yan J.J., Hsueh P.R., Ko W.C., Luh K.T., Tsai S.H., Wu H.M., and Wu J.J. Metallo-beta-lactamases in clinical Pseudomonas isolates in Taiwan and identification of VIM-3, a novel variant of the VIM-2 enzyme. Antimicrob. Agents Chemother. 45 (2001) 2224-2228
28. Yan J.J., Hsueh P.R., Lu J.J., Chang F.Y., Ko W.C., and Wu J.J. Characterization of acquired beta-lactamases and their genetic support in multidrug-resistant Pseudomonas aeruginosa isolates in Taiwan: the prevalence of unusual integrons. J. Antimicrob. Chemother. 58 (2006) 530-536